Drug intelligence / Profile preview

N-[O-Phosphono-Pyridoxyl]-Isoleucine

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-[O‑Phosphono‑Pyridoxyl]‑Isoleucine is an experimental small molecule compound structurally related to pyridoxamine 5'-phosphate and isoleucine. It has been studied primarily as a biochemical probe and inhibitor in research settings, particularly for its interaction with aminotransferase enzymes such as human mitochondrial branched chain aminotransferase (hBCATm). The compound mimics the structure of enzyme intermediates involving pyridoxal phosphate and amino acids, allowing it to act as a competitive inhibitor or mechanistic probe in enzymology studies. There are no approved therapeutic indications or clinical uses for this molecule[1][2][10].

Other names
N-(O-Phosphono-Pyridoxyl)-Isoleucine(2R,3S)-2-(((3-hydroxy-2-methyl-5-(phosphonooxy)methyl)pyridin-4-yl)methyl)amino)-3-methylpentanoic acid(2R,3S)-2-[({3-hydroxy-2-methyl-5-(phosphonooxy)methyl]pyridin–4–yl}methyl)amino]-3-methylpentanoic acidN-[O-PHOSPHONO-PYRIDOXYL]-ISOLEUCINEN-{3-hydroxy–2–methyl–5–[(phosphonooxy)methyl]pyridin–4–yl}methyl-D-alloisoleucine
02

Targets

BCAT (Branched-chain-amino-acid transaminase 1)

Beyond the preview

Go deeper on N-[O-Phosphono-Pyridoxyl]-Isoleucine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[O-Phosphono-Pyridoxyl]-Isoleucine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call